Dianthus Therapeutics, Inc. /DE/ (DNTH) has 8 open-market insider trades by 5 insiders since 2023. The most active filer is Tomas Kiselak, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Marino Garcia | CEOPres | — | 1 | $10.0M | 2026-08-07 |
| Edward Carr | CAO | — | 1 | $3.6M | 2026-09-17 |
| Simrat Randhawa | VP | — | 2 | $2.8M | 2026-09-01 |
| Tomas Kiselak | Dir10% Owner | — | 3 | $1.3M | 2024-09-27 |
| Peter Evan Harwin | Dir10% Owner | — | 1 | $673K | 2023-09-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Edward Carr | CAO | Sell | $2.0M | 2026-09-17 |
| Simrat Randhawa | VP | Sell | $2.5M | 2026-09-01 |
| Simon Read | Director | Sell | $327K | 2026-08-19 |
| Simon Read | Director | Sell | $304K | 2026-08-10 |
| Anne McGeorge | Director | Sell | $845K | 2026-08-10 |
| Adam M. Veness | CLO & VP +1 | Sell | $2.2M | 2026-08-07 |
Companies that share insiders with DNTH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Marino Garcia | CEO & President | Sell | $17.9M | 2026-08-07 |
| Ryan Savitz | CFO & VP | Sell | $3.2M | 2026-07-09 |
| Adam M. Veness | CLO & VP +1 | Sell | $2.4M | 2026-06-17 |
| Simrat Randhawa | VP | Sell | $2.4M | 2026-06-01 |
| Paula Soteropoulos | Director | Sell | $51K | 2026-05-08 |
| Ryan Savitz | CFO & VP | Sell | $739K | 2026-04-09 |
| Ryan Savitz | CFO & VP | Sell | $9.5M | 2026-03-31 |
| Paula Soteropoulos | Director | Sell | $48K | 2026-03-31 |
| Paula Soteropoulos | Director | Sell | $2.2M | 2026-03-24 |